Clinical Laserthermia Systems AB (publ)

DB:LS6 Stock Report

Market Cap: €2.5b

Clinical Laserthermia Systems Past Earnings Performance

Past criteria checks 0/6

Clinical Laserthermia Systems's earnings have been declining at an average annual rate of -14.7%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 10.9% per year.

Key information

-14.7%

Earnings growth rate

16.8%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate10.9%
Return on equity-185.8%
Net Margin-964.5%
Next Earnings Update17 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Clinical Laserthermia Systems makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:LS6 Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 238-80660
30 Sep 238-63530
30 Jun 237-77640
31 Mar 236-78640
31 Dec 226-71620
30 Sep 223-81690
30 Jun 222-63550
31 Mar 222-68570
31 Dec 212-64540
30 Sep 211-60510
30 Jun 212-57480
31 Mar 212-47400
31 Dec 201-58500
30 Sep 201-58520
30 Jun 202-57520
31 Mar 206-54550
31 Dec 196-43450
30 Sep 196-38410
30 Jun 195-37400
31 Mar 191-41410
31 Dec 188-33400
30 Sep 1810-28370
30 Jun 1811-24370
31 Mar 1812-15290
31 Dec 178-21320
30 Sep 178-22320
30 Jun 178-26340
31 Mar 176-27320
31 Dec 164-27300
30 Sep 161-27380
30 Jun 160-23300
31 Mar 160-20200
31 Dec 150-17170
30 Sep 150-21180
30 Jun 150-20130
31 Mar 150-20200
31 Dec 140-18180
30 Sep 140-1620
30 Jun 140-1600
31 Mar 140-1710
31 Dec 130-18180
30 Sep 130-1620

Quality Earnings: LS6 is currently unprofitable.

Growing Profit Margin: LS6 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LS6 is unprofitable, and losses have increased over the past 5 years at a rate of 14.7% per year.

Accelerating Growth: Unable to compare LS6's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LS6 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: LS6 has a negative Return on Equity (-185.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.